Clinical Trial Update: A Study of PER-001 in Participants With Diabetic Retinopathy [Phase 2]

View source ↗

Summary

Phase 2 trial PER-001 in participants with Diabetic Retinopathy is active but not currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diabetic Retinopathy

Drugs mentioned

• PER-001

Snippet

Sponsor: Perfuse Therapeutics, Inc. | Conditions: Diabetic Retinopathy | Phase 2 | Status: ACTIVE_NOT_RECRUITING